Search our site 
 
Advanced Search
 
Home | News | Exam dates | Contact us | About us | Testimonials |
 
 

map
You are in Home >> Resources >> Pharmacology >> Neuromuscular blockade and reversal

Mechanism of action of neuromuscular blocking drugs

Created: 1/8/2004

 
 

General mechanism of action:


Block transmission through the neuromuscular junction (NMJ) at nicotinic receptors, thus decreasing skeletal muscle tone.

NMJ blockers 

 Non-depolarising

Bind to receptors and prevent acetylcholine (Ach) from stimulating receptors
Model = Curare

Effect: compete with Ach for nicotinic receptor binding sites. The blockade is competitive, hence muscle paralysis occurs gradually.

Examples include tubocurarine, gallamine, atracurium, vecuronium, mivacurium, rocuronium  and cisatracurium. These drugs are highly ionised at body pH and contain two quaternary ammonium groups. They are poorly lipid soluble and poorly protein bound.

 Depolarising

Produce what appears to be a "persistent" depolarisation of the NMJ. Cause depolarisation by mimicking the effect of Ach but without being rapidly hydrolysed by acetylcholinesterase. Propagation of an action potential is prevented by the area of inexcitability that occurs around the Ach receptors.

Examples include suxamethonium (1951) and decamethonium (1948)
Model = succinylcholine

Action occurs in two phases:


 Phase I - initial brief depolarisation of post-junctional membrane skeletal muscle, thus causing contraction; fasciculations are seen and repolarisation is inhibited

 Phase II-"desensitisation blockade"

After the drug has been present for a period of time, the motor end plate loses its sensitivity and depolarisation cannot occur; desensitisation continues for several minutes, even after drug is no longer present. Depolarising NMJ blockers produce persistent depolarisation = desensitisation

Fasciculations can be prevented by pretreatment with a competitive agent.

Histamine release

This is a feature of tubocurare and succinylcholine (others to lesser extent)

Effects of histamine release:


 bronchospasm
 dilatation of peripheral blood vessels (decreased blood pressure)
 excessive secretions
 anticoagulant effect

Interactions of NMJ blockers 

Blockade is potentiated with general inhalational anaesthetics; antibiotics, e.g. gentamycin (decrease Ach release) and tetracyclines (chelate calcium and decrease Ach release).
Blockade is reduced with anticholinesterase agents. Results in increased Ach levels at the NMJ, thus antagonising the effects of competitive agents.

ArticleDate:20040801
SiteSection: Article
 
   
    
                                            
  Posting rules

     To view or add comments you must be a registered user and login  




Login Status  

You are not currently logged in.
UK/Ireland Registration
Overseas Registration

  Forgot your password?


Latest Discussion
View latest post MCAI (Irish) SOE/OSCE (1 Reply)
, 29/09/14
View latest post really need help calculating volume of N20 n its physics (0 Replies)
, 21/09/14
View latest post Guide to the FRCA examination The Primary (Feb 2010) (1 Reply)
, 04/07/14
View latest post Fellowships in UK (0 Replies)
, 04/11/13
View latest post job opputunity in uk/ireland post EDAIC part 2 (1 Reply)
, 21/10/13
View latest post MCAI exam (0 Replies)
, 06/09/13
 






 
All rights reserved © 2014. Designed by AnaesthesiaUK.

{Site map} {Site disclaimer} {Privacy Policy} {Terms and conditions}
This site complies with the HONcode standard for trustworthy health information:
verify here. 

 Like us on Facebook 
This website is certified by Health On the Net Foundation. Click to verify.

vp